Research and Markets: Drug Discovery Technologies - A Global Market Overview

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3z8k9j/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering.

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening.

Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

2. KEY MARKET TRENDS

3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE

4. KEY GLOBAL PLAYERS

5. KEY BUSINESS TRENDS

6. GLOBAL MARKET OVERVIEW

PART B: REGIONAL MARKET PERSPECTIVE

1. THE UNITED STATES

2. EUROPE

3. ASIA-PACIFIC

4. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

2. EUROPE

3. ASIA-PACIFIC

4. REST OF WORLD

PART D: ANNEXURE

1. RESEARCH METHOLOGY

2. FEEDBACK

Companies Mentioned:

  • 4-Antibody AG
  • Abbott Laboratories
  • Accelrys, Inc.
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Asahi Kasei Pharma Corporation
  • Astrazeneca Plc
  • Aviva Biosciences Corp.
  • Bayer Healthcare AG
  • BD Biosciences
  • Beckman Coulter Inc.
  • Biacore International AB
  • Bioanalytical Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Caliper Life Sciences, Inc.
  • Caprion Proteomics, Inc.
  • Celera Corporation
  • Celgene Corporation
  • Charles River Laboratories International, Inc.
  • Compugen Ltd.
  • Decode Genetics, Inc.
  • EMD Millipore Corporation
  • Evotec AG
  • GE Healthcare Ltd.
  • Genedata AG
  • Hitgen Ltd
  • Hudson Robotics, Inc.
  • Illumina Inc.
  • Incyte Corporation
  • Isis Pharmaceuticals, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Luminex Corporation
  • Maxcyte, Inc
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Molecular Devices, LLC
  • Molecular Discovery Ltd.
  • Molecular Discovery Systems Pty., Ltd.
  • New England Biolabs, Inc.
  • Novartis AG
  • Osiris Therapeutics Inc.
  • Perkinelmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quantum Pharmaceuticals
  • Roche Holding AG
  • Shimadzu Corporation
  • Sigma-Aldrich Corporation
  • Sri Biosciences
  • Tecan Group Ltd.
  • The National Center for Drug Screening
  • Thermo Fisher Scientific Inc.
  • Viva Biotech Ltd
  • Waters Corp.

For more information visit http://www.researchandmarkets.com/research/3z8k9j/drug_discovery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Discovery

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Discovery